Publications by authors named "Ian C Locke"

Claim this Profile
R
Regulation of TNF-Induced Osteoclast Differentiation.
Zhenqiang Yao, Stephen J Getting, Ian C Locke

Cells· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes.
Vedia C Can, Ian C Locke, Magdalena K Kaneva, Mark J P Kerrigan, Francesco Merlino

Eur J Pharmacol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(3-hydroxybutyrate)-ethyl cellulose based bio-composites with novel characteristics for infection free wound healing application.
Hafiz M N Iqbal, Godfrey Kyazze, Ian Charles Locke, Thierry Tron, Tajalli Keshavarz

Int J Biol Macromol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of bio-composites with novel characteristics: Evaluation of phenol-induced antibacterial, biocompatible and biodegradable behaviours.
Hafiz M N Iqbal, Godfrey Kyazze, Ian C Locke, Thierry Tron, Tajalli Keshavarz

Carbohydr Polym· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanocortin peptides protect chondrocytes from mechanically induced cartilage injury.
Magdalena K Kaneva, Mark J P Kerrigan, Paolo Grieco, G Paul Curley, Ian C Locke

Biochem Pharmacol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chondroprotective and anti-inflammatory role of melanocortin peptides in TNF-α activated human C-20/A4 chondrocytes.
Magdalena K Kaneva, Mark J P Kerrigan, Paolo Grieco, G Paul Curley, Ian C Locke

Br J Pharmacol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urocortin is a novel regulator of osteoclast differentiation and function through inhibition of a canonical transient receptor potential 1-like cation channel.
Charlotte E Combs, Karen Fuller, Hashethra Kumar, Anthony P Albert, Grisha Pirianov, Ian C Locke

J Endocrinol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease.
Amjad Abuirmeileh, Rebecca Lever, Ann E Kingsbury, Andrew J Lees, Ian C Locke

Eur J Neurosci· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis